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Dosage-Sensitive, Reciprocal Genetic Interactions
between the Abl Tyrosine Kinase and the Putative
GEF trio Reveal trio's Role in Axon Pathfinding
for growth cone responses are regulated tyrosine phos-
phorylation and actin-based cytoskeletal dynamics. The
involvement of tyrosine phosphorylation in growth cone
guidance has been demonstrated in a variety of experi-
mental systems. Global variation in phosphotyrosine
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mental cues that control growth cone dynamics hasGranville, Ohio 43023
2 The Ohio State University been reported for Aplysia neurons (Wu and Goldberg,
1993). Inhibiting tyrosine kinases by treating embryosDepartment of Molecular Genetics and
Neurobiotechnology Center with pharmacological agents leads to specific axon
guidance anomalies in grasshoppers (Menon and Zinn,Columbus, Ohio 43210
1998) and Xenopus (Worley and Holt, 1996). Numerous
mammalian tyrosine kinases, including the Eph, Trk, and
FGF families of receptor tyrosine kinases and the AblSummary
and Src families of nonreceptor tyrosine kinases, are
involved in axon pathfinding (ElShamy et al., 1996; Hen-The Abelson tyrosine kinase (Abl) is integrated into
signal transduction networks regulating axon out- kemeyer et al., 1996; Lowell and Soriano, 1996; McFar-
lane et al., 1996; Koleske et al., 1998). Similarly, Drosoph-growth. We have identified the Drosophila trio gene
through a mutation that exacerbates the Abl mutant ila tyrosine kinases, including the Derailed receptor
tyrosine kinase and the Abl nonreceptor tyrosine kinase,phenotype. Drosophila Trio is an ortholog of mamma-
lian Trio, a protein that contains multiple spectrin-like have been implicated in neuronal pathfinding (Hoff-
mann, 1991; Callahan et al., 1995). Further supportingrepeats and two Dbl homology (DH) domains that af-
fect actin cytoskeletal dynamics via the small GTPases the hypothesis that regulated tyrosine phosphorylation
is essential in the growth cone, a variety of axon path-Rho and Rac. Phenotypic analysis demonstrates that
trio and Abl cooperate in regulating axon outgrowth in finding defects have been found in Drosophila embryos
mutant for neuronally expressed tyrosine phosphatasesthe embryonic central nervous system (CNS). Dosage-
sensitive interactions between trio and Abl, failed axon (Desai et al., 1996; Krueger et al., 1996; Sun et al., 2000).
Directional actin polymerization within the growthconnections (fax), and enabled (ena) indicate that Trio
is integrated into common signaling networks with cone filopodia is believed to be a primary event in tar-
geted growth cone outgrowth (Mallavarapu and Mitchi-these gene products. These observations suggest a
mechanism by which Abl-mediated signaling net- son, 1999), while actin-myosin contractile fibers are in-
volved in growth cone retraction (Luo et al., 1997; Hall,works influence the actin cytoskeleton in neuronal
growth cones. 1998). Cytochalasin treatment of grasshopper embryos
(Bentley and Toroian-Raymond, 1986) or Drosophila em-
bryos (Kaufmann et al., 1998) results in disoriented neu-Introduction
ronal pathfinding. In Drosophila, expression of constitu-
tively active versions of the Rac1 GTPase results inDuring the development of the central nervous system
abnormal F-actin accumulation in neurons and axon(CNS), neuronal growth cones receive and process a
outgrowth phenotypes (Luo et al., 1994). Likewise, ex-variety of attractive and repulsive pathfinding cues (Tes-
pression of dominant-negative versions of Rac1 resultssier-Lavigne and Goodman, 1996). For example, guidance
in a variety of axon guidance defects (Luo et al., 1994;cues of the Slit and Netrin families have been shown to
Kaufmann et al., 1998).bind the Roundabout family and Deleted in Colorectal
Recent genetic and biochemical analyses have begunCancer (DCC) family of transmembrane receptors, re-
to suggest functional interactions between tyrosinespectively, initiating molecular cascades that result in
phosphorylation and microfilament dynamics in theeither growth cone repulsion or attraction (Keino-Masu
growth cone. In Drosophila, second site modifieret al., 1996; Kidd et al., 1999). Although the molecular
screens have found that heterozygosity for enableddetails of the intracellular machinery that responds to
(ena) alleviates the Abl mutant phenotype (Gertler et al.,these attractive and repulsive cues is being actively in-
1990). Enabled can bind to and be phosphorylated byvestigated, they are not yet fully characterized. Two
Abl and can bind to and be dephosphorylated by Dlar,intracellular events that are at least in part responsible
and Enabled's phosphorylation state is believed to influ-
ence its protein±protein interactions (Gertler et al., 1995;3 To whom correspondence should be addressed (e-mail: liebl@
Comer et al., 1998; Wills et al., 1999a). As Enabled candenison.edu).
4 Present address: Department of Biology, Washington University, bind Profilin (Ahern-Djamali et al., 1998) and is colocal-
St. Louis, Missouri 63110. ized with Abl and Dlar in axons (Bennett and Hoffmann,
5 Present address: College of Medicine, The Ohio State University, 1992; Gertler et al., 1995; Krueger et al., 1996) tyrosine
Columbus, Ohio 43210.
phosphorylation of Enabled may be one way to influence6 Present address: Medical College of Ohio, Toledo, Ohio 43614.
F-actin production in the growth cone and therefore7 Present address: College of Medicine, University of Cincinnati, Cin-
cinnati, Ohio 45229. may be an important influence on Drosophila axonal
Neuron
108
pathfinding. Work in mice suggests that similar molecu- The Szeged P[w1] insertion line l(3)0368/10, with a single
lar cascades function in mammals; Mena, which pro- P[w1] insertion in 61E (Deak et al., 1997), failed to com-
motes actin polymerization and binds Profilin, is concen- plement the M89, Abl1 chromosome (Table 2) but com-
trated in filopodia tips of growth cones, and Mena null plemented the parental Abl1 chromosome (data not
mice have axonal projection defects (Gertler et al., 1996; shown). After mobilizing the P[w1] in line 0368/10, 95%
Lanier et al., 1999). (103 of 108) of the chromosomes tested that had lost
Genetic analysis in Drosophila has been used to iden- the P[w1] complemented the M89, Abl1 chromosome,
tify a variety of other genes having dosage-sensitive suggesting that the P[w1] insertion generates a novel
interactions with Abl, as dosage-sensitive genetic inter- allele of the gene containing the M89 mutation.
actions can occur between members of signal transduc- Sequencing flanking genomic DNA obtained by plas-
tion networks (Hoffmann, 1991; Simon et al., 1991; Guar- mid rescue revealed that the P[w1] in line 0368/10 is
ente, 1993). Reducing the gene dose by half of either inserted into a partial Tn Doc element (Bender et al.,
disabled (dab), failed axon connections (fax), or Notch 1983; data not shown). Unique (non±Tn Doc) sequences
has been shown to worsen the Abl mutant phenotype from this flanking genomic DNA were used to screen
(Gertler et al., 1989; Hill et al., 1995; Ginger, 1998), while a 0±18 hr embryonic cDNA library, and a full-length
reducing the dose of Abl by half has been shown to cDNA was constructed combining sequences identified
worsen the profilin (chic) mutant phenotype (Wills et al., through the Berkeley Drosophila Genome Project. We
1999b). Reducing the gene dose of Abl has also been have named the gene encoding this cDNA Drosophila
shown to alleviate the Dlar mutant phenotype (Wills et trio (see below).
al., 1999a). It is likely that these genes' products are
integrated into molecular networks regulating growth trio Encodes a Protein Highly Similar to the N-terminal
cone guidance, although the biochemical interaction be- 80% of Human Trio
tween these molecules and Abl is not yet established The sequence of this full-length trio cDNA revealed
in all cases. an open reading frame of 2263 amino acids with a pre-
We have identified a novel, dosage-sensitive genetic dicted molecular weight of 257 kDa (Figure 1). Database
interaction between Abl and a neuronally expressed, searches with this amino acid sequence revealed signifi-
putative Rac/Rho guanine nucleotide exchange factor cant homology to the Trio and Kalirin mammalian pro-
(GEF). The structural organization of this Drosophila pro- teins and the C. elegans UNC-73A protein (Debant et
tein is highly similar to the N-terminal 80% of the human al., 1996; Alam et al., 1997; Steven et al., 1998). The
protein Trio (Debant et al., 1996), and so we have named human Trio protein was identified through its ability to
this gene Drosophila trio. Not only do heterozygous associate with the LAR receptor tyrosine phosphatase
mutations in trio dramatically enhance the Abl mutant in the yeast two-hybrid system. Kalirin is a rat protein
phenotype, but reducing the gene dose of either Abl, identified in the yeast two-hybrid system through its
fax, or dab enhances the trio mutant phenotype. Het- ability to bind to peptidylglycine a-amidating monooxy-
erozygosity for ena partially alleviates the trio mutant
genase (PAM). UNC-73A was recently identified as influ-
phenotype. These dosage-sensitive genetic interactions
encing axon pathfinding and actin polymerization.
between trio, Abl, and genes believed to be in Abl-medi-
Figure 1 shows the alignment of the conceptual trans-ated signal transduction networks, as well as the poten-
lation of the Drosophila trio cDNA with the human Triotial for Trio to regulate the actin cytoskeleton by influenc-
protein. Conserved regions include the N-terminal re-ing small GTPases, position the Trio protein as another
gion (Drosophila Trio residues 5±232), a region con-candidate for the integration of tyrosine phosphorylation
taining at least four spectrin repeats (Drosophila Trioand microfilament dynamics in the growth cone.
residues 284±1199), an SH3-like domain (Drosophila Trio
residues 1643±1707), the two Dbl homology (DH) do-Results
mains (Drosophila Trio residues 1281±1464, 1939±2131),
and two pleckstrin homology (PH) domains (DrosophilaIdentification of the trio Gene via the M89
Trio residues 1474±1583, 2140±2247). Figure 2A showsHDA Mutation
the domain structure of Drosophila Trio aligned withAn ethylmethane sulfonate± (EMS-) induced allele, origi-
similar representations of human Trio and UNC-73A.nally identified as M89, showed haploinsufficiency de-
Although human Trio contains a C-terminal Ig-like do-pendent on Abl mutations, or the HDA effect (Hoffmann,
main, a second SH3-like domain, and a serine protein1991; Hill et al., 1995). M89's dosage-sensitive exacer-
kinase domain, all of which are lacking in Drosophilabation of the Abl mutant phenotype was used to map the
Trio, the overall arrangement of the N-terminal domain,M89 mutation by testing for the HDA effect in individual
the spectrin repeats, the DH/PH domains, and the firstchromosomes that were recombinational products be-
SH3-like domain is highly similar between Drosophilatween the M89, Abl1 chromosome and the multiply
Trio and human Trio (Debant et al., 1996; Seipel et al.,marked ru, h, th, st, cu, sr, e, ca (rucuca) chromosome.
1999).One hundred percent (110 of 110) of the ru, Abl1 chromo-
Several lines of evidence suggest that the Drosophilasomes had lost the HDA effect, placing the M89 mutation
trio gene does not encode a C-terminal region similarvery close to roughoid. Complementation analyses us-
to that of human Trio or UNC-73A. First, 39 RACE experi-ing deficiencies in this region placed the M89 mutation
ments with embryonic cDNA failed to identify alternativein cytological region 61D3;61F2, based on the ability of
39 ends. Second, Northern blot analysis of embryonicDf(3L)emc-E12 (61A;61D3) to complement the M89 muta-
RNA revealed a prominent z8000 nucleotide transcript,tion and on the inability of Df(3L)FpaI (61D1±2;61F1±2) to
complement the M89 mutation. corresponding to the total size of our full-length trio
Drosophila trio Functions in Axon Guidance
109
Figure 1. Alignment of the Human and Drosophila Trio Proteins
Predicted 2263 amino acid sequence of the Drosophila Trio protein (dTrio; AF216663) aligned with the 2861 amino acid human Trio protein
(hTrio; U42390). Residue numbers are indicated on the right. Identical residues are indicated by reverse text. The N-terminal domains are
indicated by plus signs. The regions containing at least four spectrin repeats are indicated by solid underlining. DH domains are indicated
by dashed underlining. PH domains are indicated by double dashed underlining. The SH3-like domain in dTrio is indicated by starred underlining.
cDNA (data not shown). A minor transcript of z8900 trio mRNA is unknown at present, our full-length (8033
bp) trio cDNA proved sufficient to rescue trio mutantnucleotides was also observed. However, since both
the 8000 and 8900 nucleotide transcripts were identified phenotypes in the CNS (see below).
with probes specific to the trio 39 untranslated region,
we conclude that these different transcripts cannot arise Molecular Basis of trio Alleles
The intron/exon structure of the coding portion of thefrom alternative splicing at the 39 end of the trio gene
(see intron/exon organization of trio, Figure 2B). Al- trio gene has been determined (Figure 2B). Sequencing
genomic DNA from both the EMS-induced M89 mutationthough the precise composition of the 8900 nucleotide
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Figure 2. Domain Arrangement and Genomic
Organization of Drosophila Trio
(A) The spatial arrangement of these proteins'
domains is shown. Numbers indicate percent
amino acid identity between indicated do-
mains in alignments done with Clustal-X. DH
domain, PH domains, immunoglobulin-related
domains (Ig), and fibronectin type III domains
(FnIII) are indicated.
(B) Comparison of cDNA and genomic DNA
sequence identified the intron/exon organi-
zation of the trio transcriptional unit. The 16
coding exons are represented as shaded
boxes, while 59 and 39 untranslated regions
are represented as open boxes. The trio tran-
scription start site has not been determined.
AUG and UGA indicate the initiating methio-
nine codon and the stop codon, respectively.
The open reading frame is organized as fol-
lows: exon 1, amino acids M1±S60; exon 2,
D61±Q241; exon 3, A242±Q943; exon 4, I944±
Q1570; exon 5, I1571±K1638; exon 6, L1639±
S1737; exon 7, N1738±G1756; exon 8, R1757±
R1787; exon 9, T1758±M1873; exon 10,
A1874±T1895; exon 11, E1896±E1927; exon
12, S1928±G1966; exon 13, Y1967±D2005;
exon 14, F2006±D2068; exon 15, L2069±
Q2195; and exon 16, L2196±K2263. All introns
are shorter than 100 base pairs, except be-
tween exons 1 and 2, 2 and 3, 5 and 6, 7 and
8, and 9 and 10. The position of the C-to-T
transition in coding exon 4, which produces
a missense mutation (L1412F) in the trioM89 allele, is indicated by an asterisk. The insertion site of the P[w1] transposable element in trioP0368/10
(z11 kb in total length, not shown to scale) and a restriction map indicating EcoRI (E) and HindIII (H) sites are shown above the intron/exon
structure.
(hereafter referred to as trioM89) and its parental trio1 in the developing nervous system was evident during
stage 10 (Figure 3B). Expression in the nervous systemallele has revealed a C-to-T transition, resulting in a
missense mutation in codon 1412 (L1412F) within the persisted through approximately stage 15 (Figures 3C,
3D, and 3F). It appeared that most, if not all, neuronsfirst DH domain in trioM89. This C-to-T transition is entirely
compatible with the action of the alkylating agent EMS of the CNS expressed trio mRNA (Figure 3F). In addition,
we observed low levels of trio expression throughout(Ashburner, 1989). Trio residue L1412 is analogous to
residue L343 in the human Sos1 protein's DH domain. the epidermis at these stages. Patches of trio expression
in the lateral epidermis became evident in stage 13 em-This is a highly conserved residue within the conserved
region 3 (CR3) of the DH domain (Soisson et al., 1998). bryos (Figures 3E and 3F). This accumulation corre-
sponded to muscle attachment sites for the somaticThe P[w1] insertion site in line 0368/10 (hereafter re-
ferred to as trioP0368/10) has been mapped to the intron musculature (Bate, 1993; Frommer et al., 1996). During
the process of dorsal closure, increased levels of triobetween coding exons 7 and 8 (Figure 2B). The 39 end
of coding exon 7 and the 59 end of coding exon 8 span mRNA accumulation were observed in leading edge
cells that were enclosing the yolk sack along the dorsala glycine codon (G1756) between the SH3-like domain
and the second DH domain in Trio. The molecular basis surface (Figure 3G). By stage 16, the majority of trio
mRNA accumulation became restricted to cells sur-of the trioP0368/10 allele is unknown at present, as aber-
rantly sized trio transcripts have not been detected from rounding the developing gut (Figure 3H). Sense ribo-
probes showed no staining, confirming that trio mRNAthe 0368/10 line (data not shown).
was specifically recognized in these experiments (data
not shown). Throughout embryonic development, triotrio Is Expressed in the Developing CNS
To examine the temporal and spatial expression of trio expression appeared most prominently in cells that
were migrating or undergoing dynamic cytoskeletal re-during development, in situ analysis of Canton-S wild-
type embryos was performed with antisense riboprobes. arrangements.
Extensive accumulation of trio mRNA was observed in
early cleavage stage embryos, indicating maternal con- Reducing the Gene Dose of trio Exacerbates
the Abl Mutant Phenotypetribution of the trio mRNA (Figure 3A). By the cellular
blastoderm stage, levels of trio mRNA were greatly re- The EMS-induced trioM89 allele was isolated by its ability
to enhance the Abl mutant phenotype in a dosage-sensi-duced compared with the earlier maternal contribution.
As germband extension proceeded, mRNA accumula- tive manner, shifting the lethal phase to prepupal stages
(Table 1). This haploinsufficiency dependent on Abl mu-tion in the invaginating mesodermal layer was detected
(data not shown). The first accumulation of trio mRNA tations, or HDA effect (Gertler et al., 1989; Hoffmann,
Drosophila trio Functions in Axon Guidance
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Figure 3. Expression of trio Transcripts in Wild-Type Embryos
Embryos were staged by CNS and gut morphology.
(A) An early cleavage stage embryo showing maternal loading of trio mRNA.
(B) The beginning of segmentally repeated neuroblast staining is evident in stage 10 (arrows). Mesodermal expression is still evident.
(C and D) Strong CNS expression is observed through germband retraction.
(E and F) Segmentally repeated expression of trio in the lateral epidermis, corresponding to muscle attachment sites, is evident in stage 13
(arrows).
(F) Ventral view showing diffuse expression of trio throughout the nerve cord in a stage 14 embryo.
(G) Dorsal view showing trio expression in leading edge cells during dorsal closure (arrows).
(H) Stage 16 embryo showing trio expression in cells surrounding the gut.
1991), is similar to that observed for mutations in dab single wild-type Abl minigene, P[Abl1] (Henkemeyer et
al., 1990), fully restores viability (Table 1).and fax (Table 1) (Gertler et al., 1989; Hill et al., 1995). The
trioM89 allele is not haploinsufficient itself, as providing a As the trioM89 allele contains a missense mutation (see
Table 1. Dosage-Sensitive Modification of the Abl Mutant Phenotype
Wild-type Dose of:
Genotype trio Abl fax dab ena Pupaea Adultsa
Abl1/Abl4 2 0 2 2 2 82 51
trioM89, Abl1/Abl4 1 0 2 2 2 10 0
Df(3L)FpaI, Abl1/Abl4 1 0 2 2 2 21 1
P[Abl1]; trioM89, Abl1/Abl4 1 1 2 2 2 97 100
faxM7, Abl1/Abl4 2 0 1 2 2 7 0
Abl1, dabM221/Abl4 2 0 2 1 2 13 0
enaGC10/1; Abl1/Abl4 2 0 2 2 1 96 103
enaGC10/1; trioM89, Abl1/Abl4 1 0 2 2 1 64 17
enaGC10/1; faxM7, Abl1/Abl4 2 0 1 2 1 40 20
enaGC10/1; Abl1, dabM221/Abl4 2 0 2 1 1 84 61
a The percent of the expected progeny class of both pupae and viable adults of the indicated genotype is shown. A minimum of 1300 animals
were counted in each cross, and values are normalized to an appropriate control cross.
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above), we asked whether the trioM89 allele is unique in its for Abl (Abl1/Abl4) exhibited clear disruptions of commis-
sures in 8% of segments scored (n 5 240). Typical exam-exacerbation of the Abl mutant phenotype, or whether
simply reducing the trio gene dose by half would show ples of what was scored as a disrupted commissure are
indicated in Figures 4C and 4D. Only segments thatsimilar dosage effects with Abl. As shown in Table 1,
a chromosomal deficiency that removes the trio gene, lacked a commissure(s) or exhibited dramatic thinning of
commissures were considered mutant. When embryosDf(3L)FpaI, also showed the HDA effect.
As both trio and Abl are expressed in multiple tissues were also heterozygous mutant for trio (trioM89, Abl1/Abl4,
or Df(3L)FpaI, Abl1/Abl), the frequency of commissureduring development (see above; Bennett and Hoffmann,
1992), the dosage-sensitive shift to prepupal lethality disruption increased to 31% (n 5 210) and 42% (n 5
230), respectively. This enhancement of the Abl mutantseen in trio heterozygous, Abl homozygous mutants may
be due to disruption of any number of developmental phenotype by mutations in trio could be rescued by
introducing an Abl minigene, P[Abl1], into this trio het-processes. However, as Abl and dab, and Abl and fax,
show dosage-sensitive disruptions of axon outgrowth erozygous, Abl homozygous mutant background (data
not shown). In this background, 0% of the segmentsand/or pathfinding (Gertler et al., 1989; Gertler et al.,
1993; Hill et al., 1995), we have examined embryonic assayed exhibited defects in commissure formation
(n 5 90).CNS phenotypes in a variety of trio and Abl mutant
backgrounds. Similar to the exacerbation of the Abl mutant pheno-
type by trio, heterozygous mutations in Abl exacerbate
the trio homozygous mutant phenotype, although gener-
ally less severely. Phenotypes of homozygous trio, het-Mutations in Abl and trio Exert Synergistic Effects
on the Developing CNS erozygous Abl mutant embryos (Df(3L)FpaI/trioM89, Abl1)
are shown in Figures 4F and 4N. Slightly more severeThe phenotypic consequences of the dosage-sensitive
genetic interactions between trio and Abl were explored disruptions of the axon scaffolding (reduced longitudi-
nals and thin commissures) were observed in these mu-on the embryonic CNS. Two mAbs were utilized to ac-
cess CNS phenotypes: mAb BP102, to visualize the gen- tant embryos compared with trio homozygous mutants
alone (compare Figures 4E and 4F). These enhancederal axon scaffolding (Figures 4A±4H), and mAb 1D4, to
visualize a subset of longitudinal axon pathways (Fig- phenotypes were also reflected in more severe disrup-
tions of Fas II±positive axon pathways (compare Figuresures 4I±4P) (Seeger et al., 1993; Lin et al., 1994). Embryos
homozygous mutant for Abl (Abl1/Abl4) showed no gross 4M and 4N). Embryos homozygous mutant for trio
(trioM89/Df(3L)FpaI) exhibited commissure disruptions indefects in axon pathfinding when stained with mAb
BP102 (Figure 4B), although many mutant embryos did 0% of the segments assayed (n 5 200) and disruptions
of the lateralmost Fas II±positive fascicle in 58% of theexhibit some thinning of the commissures and longitudi-
nal connectives. These relatively minor defects in axon hemisegments assayed (n 5 100). When these embryos
were also heterozygous mutant for Abl (Df(3L)FpaI/pathfinding were more clearly revealed when embryos
of the same genotype were stained with mAb 1D4 (Figure trioM89, Abl1), the frequency of commissure disruption
increased very slightly to 1.5% (n 5 210), while disrup-4J). Disruptions of the most lateral mAb 1D4± (Fas II±)
positive fascicle were frequently observed, along with tions of the lateralmost Fas II±positive fascicle increased
to 98% (n 5 80).less frequent disruptions of the two medial Fas II±
positive pathways. These results were similar to previ- Embryos homozygous mutant for both Abl and trio
(Df(3L)FpaI, Abl4/trioM89, Abl1) exhibited dramatic disrup-ous reports of the Abl mutant CNS (Elkins et al., 1990;
Hu et al., 1998; Wills et al., 1999b). Similar to Abl mutants, tions of the CNS axon scaffolding. Commissures fail
to form in these double homozygous mutant embryosembryos homozygous mutant for trio (trioM89/Df(3L)FpaI)
exhibit no gross CNS defects when visualized with mAb (Figure 4G). This phenotype was observed in all mutant
embryos, with 100% of the segments exhibiting com-BP102 (Figure 4E). Defects in axon pathfinding were
observed with mAb 1D4, including frequent disruptions missure disruptions (n 5 200). Disruptions of longitudi-
nal pathways between segments were also observedof the lateral Fas II±positive fascicle (Figure 4M). Thus,
mutations in either Abl or trio alone lead to relatively with mAb BP102 (Figure 4G) and mAb 1D4 (Figure 4L).
The ability to discern three distinct Fas II±positive path-minor defects in axon pathfinding.
ways was lost in these double homozygous mutant em-Embryos heterozygous mutant for trio and homozy-
bryos, reflecting major defects in axon guidance. De-gous mutant for Abl (trioM89, Abl1/Abl4) showed clear de-
spite these dramatic disruptions within the developingfects in axon guidance, including reduced commissures
CNS, motoneurons still exited the CNS (data not shown).and thinning of longitudinal tracts (Figure 4C). When
Interestingly, the phenotype of the homozygous trio,analyzed with mAb 1D4, these embryos showed severe
Abl mutant embryos is quite similar to that of embryosdisruptions of Fas II±positive pathways (Figure 4K). Fas
deficient for both Abl and Fas I (see Elkins et al., 1990).II±positive fascicles exhibited frequent disruptions be-
tween segments, and the normal organization of three
distinct pathways was often absent. This same exacer- The trio cDNA Rescues the Abl, trio Homozygous
bation of the Abl mutant phenotype by the trioM89 allele Mutant Phenotype
could be generated with a deficiency for the trio region, As confirmation that the trio cDNA we have isolated
Df(3L)FpaI (Figure 4D). These results are most easily encodes a functional Trio protein, we have tested the
quantified by looking at either disruption of commis- cDNA's ability to rescue the dramatic CNS defects ob-
sures with mAb BP102 or disruption of Fas II±positive served in trio, Abl homozygous mutant embryos (see
Experimental Procedures). As shown in Figure 4H,fascicles with MAb 1D4. Embryos homozygous mutant
Drosophila trio Functions in Axon Guidance
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Figure 4. The CNS Axonal Defects Associ-
ated with Abl and trio Mutants
Embryos of different genotypes were stained
with either mAb BP102 to visualize the gen-
eral axon scaffolding of the embryonic CNS
(A±H) or mAb 1D4 to visualize a subset of
longitudinal axon fascicles (I±P). Dissected
CNSs were from stage 14/15 embryos (A±H)
and stage 15/16 embryos (I±P). Genotypes
are as follows: wild-type (A and I), Abl1/Abl4 (B
and J), trioM89, Abl1/Abl4 (C and K), Df(3L)FpaI,
Abl1/Abl4 (D), trioM89/Df(3L)FpaI (E and M),
Df(3L)FpaI/trioM89, Abl1 (F and N), Df(3L)FpaI,
Abl4/trioM89, Abl1 (G and L), P[UAS-trio]/P[sca-
GAL4]; Df(3L)FpaI, Abl4/trioM89, Abl1 (H),
trioP0368/10/trioM89 (O), and trioP0368/10/trioM89, Abl1
(P). Arrows in (C) and (D) indicate segments
scored as having disrupted commissures.
Arrows in (J), (K), and (M) through (P) illustrate
examples of disruptions in Fas II±positive fas-
cicles.
panneural expression of trio via the scabrous GAL4 trioP0368/10/trioM89 adults recovered displayed an unin-
flated, blistered wing phenotype with 23% penetrance,driver in the GAL4/UAS system (Brand and Perrimon,
1993) provided robust rescue of the trio, Abl mutant but otherwise appeared wild-type. Using this sensitized,
adult, viable trio mutant background, we have testedembryos. Commissure disruptions were found in only
28% of segments assayed (n 5 86). As these embryos for dosage-sensitive effects on viability. In these assays
Abl and genes previously identified through genetic in-were still homozygous mutant for Abl, thinning of longi-
tudinal tracts was still observed (Figure 4H). teractions with Abl (fax and dab) show dosage-sensitive
interactions with trio.
A reduction in the dose of either Abl or fax showed aDosage-Sensitive Exacerbation of a trio
Hypomorphic Mutant Phenotype dramatic worsening of the trio hypomorphic phenotype,
with many fewer animals surviving to either pupal orAnimals homozygous mutant for trio (Df(3L)FpaI/trioM89)
rarely survive to pupae and never to adults (Table 2). adult stages (Table 2). Adult escapers from all of these
tests (heterozygous mutant for either Abl or fax andHowever, the trioP0368/10 allele (see above) has proven to
be a hypomorphic allele of trio, allowing us to create hypomorphic mutant for trio) showed high penetrance
for the uninflated, blistered wing phenotype (100% foran adult, viable trio mutant background (Table 2). The
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Table 2. Dosage-Sensitive Modification of the trio Mutant Phenotype
Wild-type Dose of:
Genotype triob Abl fax dab ena Pupaea Adultsa
Df(3L)FpaI/trioM89 0 2 2 2 2 7 0
enaGC10/1; Df(3L)FpaI/trioM89 0 2 2 2 1 44 0
trioP0368/10/trioM89 0.5 2 2 2 2 87 82
trioP0368/10/trioM89, Abl4 0.5 1 2 2 2 54 13
trioP0368/10/trioM89, Abl1 0.5 1 2 2 2 23 5
trioP0368/10, faxM7/trioM89 0.5 2 1 2 2 24 4
P[Abl1]; trioP0368/10, In(3L)std11/trioM89 0.5 2 2 1 2 54 48
a The percent of the expected progeny class of both pupae and viable adults of the indicated genotype is shown. A minimum of 1300 animals
were counted in each cross, and values are normalized to an appropriate control cross.
b The trioP0368/10 allele has been indicated as 0.5 of a wild-type gene dose to reflect its hypomorphic character.
Abl1, 89% for Abl4, 72% for faxM7). A null allele of dab Discussion
(P[Abl1]; In(3L)std11; see Experimental Procedures)
The Drosophila trio gene is a member of a growing familyshowed weaker enhancement of the trio hypomorphic
of genes that encode multiple N-terminal spectrin re-mutant background (Table 2). Similar to the simple trio
peats and two DH/PH domains. Included in this grouphypomorphic mutant phenotype, 21% of dab heterozy-
are the human protein Trio and the C. elegans proteingous, trio hypomorphic adults recovered had blistered
UNC-73A (Debant et al., 1996; Steven et al., 1998). Dro-wings.
sophila trio has been independently isolated by threeAs with the exacerbation of the Abl mutant phenotype,
other groups (Awasaki et al., 2000 [this issue of Neuron];these dosage-sensitive effects on the viability of trio
Bateman et al., 2000 [this issue of Neuron]; Newsomehypomorphic animals could be due to disruptions of any
et al., 2000 [the April 28 issue of Cell]). The first DHnumber of developmental processes. To see if axon
domain in both human Trio and UNC-73A has beenoutgrowth within the developing CNS may play a part
shown to be enzymatically active toward mammalianin these phenotypes, we have examined the CNS of
Rac1, while the second DH domain of human Trio showsthese embryos. Hypomorphic trio mutant embryos
specificity toward mammalian RhoA (Debant et al., 1996;(trioP0368/10/trioM89) displayed mAb 1D4 phenotypes quali-
Steven et al., 1998). Rac and Rho are small GTPasestatively similar to, although less severe than, trioM89/
that affect F-actin dynamics in all eukaryotic cell types;Df(3L)FpaI embryos (compare Figures 4O and 4M). Dis-
Rac promotes the formation of lamellipodia and mem-ruptions of lateralmost Fas II±positive fascicle were ob-
brane ruffles by inducing microfilament polymerization,served in 14% (n 5 104) and 58% (n 5 100) of these
while Rho induces the formation of contractile actin-hemisegments, respectively. This phenotype was en-
myosin filaments (reviewed by Hall, 1998). In the contexthanced by decreasing the dosage of Abl in this trio
of the growth cone, Rac activation leads to lamellipodiahypomorphic background (trioP0368/10/trioM89, Abl1; Figure
formation that extends the growth cone, while Rho acti-4P), as 47% of these hemisegments (n 5 106) showed
vation leads to growth cone retraction (reviewed by Luodisruptions of the lateralmost Fas II±positive fascicle.
et al., 1997).
Expression of full-length human Trio has been shown
to affect actin-based structures in vivo (Seipel et al.,Dosage-Sensitive Interactions between trio and ena
Heterozygous mutations in ena were tested for viability 1999). Consistent with each domain's GEF specificity,
expression of the first DH domain of human Trio pro-effects on two different consequences of trio mutations:
trio's exacerbation of the Abl mutant phenotype and motes membrane ruffles, while the second DH domain
promotes stress fiber formation (Bellanger et al., 1998;the trio mutant phenotype. In agreement with previous
reports, the simple Abl mutant phenotype and the exac- Seipel et al., 1999). Similarly, in REF-52 cells, expression
of Drosophila Trio's first DH domain promotes mem-erbation of the Abl mutant phenotype by dab were both
alleviated by reducing the gene dose of ena (Table 1) brane ruffling, while expression of Drosophila Trio's sec-
ond DH domain promotes actin stress fiber formation(Gertler et al., 1990). In contrast, the exacerbation of the
Abl mutant phenotype by heterozygous mutations in (Newsome et al., 2000). As the trio transcript is strongly
expressed in the developing nervous system (Figure 3),either trio or fax was much less sensitive to ena muta-
tions (Table 1). Results similar to those reported with and trio mutations show effects on axon pathfinding, as
visualized with either mAb BP102 or mAb 1D4 (Figurethe enaGC10 were obtained with the enaGC8 allele (data not
shown). 4), it is likely that Drosophila Trio acts to influence the
actin cytoskeleton in the growth cone.The strong prepupal lethality of trio mutants was also
tested for sensitivity to ena mutations. Heterozygous The identification of trio as the HDA gene originally
identified through the M89 mutation has been confirmedmutations in ena partially alleviated the Df(3L)FpaI/trioM89
prepupal lethality, allowing many more animals to sur- by three independent means. First, a missense mutation
in the trio gene has been identified in the trioM89 allele.vive to pupariation. However, Df(3L)FpaI/trioM89 adults
were never recovered, regardless of the state of ena The EMS-induced trioM89 allele has a C-to-T transition
within codon 1412 of the trio gene (Figure 2B). This(Table 2).
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alteration produces a missense mutation (L1412F), alter- In addition to the reciprocal genetic enhancement be-
ing a highly conserved residue within the first DH do- tween Abl and trio (see above), we have found that a null
main. By analogy to the crystal structure of the DH/ allele of fax (faxM7) greatly worsens the trio hypomorphic
PH domains of the human Sos1 protein (Soisson et al., mutant's viability, while a dab null allele weakly modifies
1998), this residue projects into a hydrophobic pocket this background (Table 2). We are currently working to
at the confluence of helices that form the DH catalytic test if these effects on viability are correlated with effects
domain. Preserving the hydrophobic character of this on these mutants' embryonic CNS.
residue, yet altering its space-filling properties, may alter The ena gene was identified through its ability to sup-
the conformation of this DH domain. Indeed, modeling press the Abl mutant phenotype (Gertler et al., 1990).
has suggested that the L1412F mutation will result in As reductions in ena compensate for the absence of
an alteration of the packing between F1412 and F1331 Abl, it has been hypothesized that a precise balance
within the hydrophobic pocket. Drosophila Trio residue between Abl and Enabled activity is required for viability
F1331 is analogous to F246 in human Sos1, an invariant (Gertler et al., 1995; Wills et al., 1999a). Similar to the
residue within DH domains (Soisson et al., 1998). We genetic interaction between Abl and ena, heterozygous
hypothesize that the selective disruption of the tertiary mutations in ena can partially alleviate the trio mutant
structure of the first DH domain in the trioM89 allele con- phenotype (Table 2). One interpretation of this interac-
tributes to its strong dosage-sensitive interaction with tion is that a balance between trio and ena is required,
Abl (Table 1; Figure 4C). Second, panneural GAL4/UAS and Trio may possess a biochemical function that is
driven expression of the trio cDNA can compensate for antagonistic to Enabled's. As neural enriched isoforms
trio mutations (Figure 4H). Third, a P[w1] insertion allele of the murine homolog of Enabled, Mena, are believed
(trioP0368/10) maps to an intron within the trio gene (Figure to be involved in filopodia formation to extend the
2B), and loss of the P[w1] reverts the trio allele to wild- growth cone (Lanier et al., 1999), a potential antagonistic
type with high frequency. role for Trio is the retraction of growth cones. Drosophila
We find the dosage-sensitive genetic interactions Trio's second DH domain stimulates the formation of
between trio and Abl intriguing. While the biochemical stress fibers in REF-52 cells (Newsome et al., 2000). In
extrapolation of genetic enhancement is not straightfor- neurons, the formation of similar actin-myosin contrac-
ward (Guarente, 1993), there is precedence for dosage- tile filaments leads to neurite retraction (Luo et al., 1997;
sensitive interactions between a GEF and a tyrosine Hall, 1998). Therefore, a balance between Enabled's and
kinase, revealing these proteins' involvement in a com- Drosophila Trio's biochemical activities may be required
mon signal transduction pathway. Alleles of Sos were for a proper balance between extension and retraction of
isolated as dosage-sensitive modifiers of the sevenless the growth cone in response to attractive and repulsive
mutant phenotype (Rogge et al., 1991; Simon et al., pathfinding cues.
1991). Of course, we do not envision that the stimulation of
A number of observations support the interaction of stress fiber formation leading to neurite retraction is the
Abl and Trio in a common regulatory network. First, the only possible biochemical function of Trio. In fibroblasts,
dosage-sensitive genetic interactions between trio and human Trio activates Rac1 with its first DH domain,
Abl are reciprocal, as assayed by either viability or CNS inducing the formation of lamellipodia and membrane
architecture. Heterozygous mutations in trio worsen the ruffles (Bellanger et al., 1998; Seipel et al., 1999). Similar
Abl mutant phenotype (Table 1; Figures 4C, 4D, and 4K), biochemical activity reported for Drosophila Trio's first
while heterozygous mutations in Abl worsen trio mutant DH domain (Newsome et al., 2000) would presumably
phenotypes (Table 2; Figures 4F, 4N, and 4P). A back- lead to lamellipodia/filopodia formation analogous to
ground of compromised signaling (Abl1/Abl4, Df(3L)FpaI/ Enabled's activity in the growth cone. The elucidation
trioM89, or trioP0368/10/trioM89) is enhanced by reduced activ- of the biochemical interrelationships between Abl, Ena,
ity of another member of this network. Fax, and Trio suggested by their genetic interactions
As further evidence for the involvement of Abl and
awaits detailed analyses.
Trio in a common signaling network, the Abl and trio
In addition to a role for trio during development of the
homozygous mutant phenotypes show a synergistic in-
CNS, our observations of trio expression in leading edgeteraction. Neither the Abl mutant background (Figures
cells during dorsal closure (Figure 3G) and an uninflated,4B and 4J) nor the trio mutant background (Figures 4E
blistered wing phenotype in the trio hypomorphic back-and 4M) have dramatic phenotypic consequences on
ground suggest additional roles for trio during develop-CNS architecture. Phenotypes similar to those reported
ment. Harden and colleagues (1995, 1999) have shownhere have been observed in a variety of trio mutant
that dominant-negative Rho subfamily constructs cancombinations (Awasaki et al., 2000; Bateman et al.,
disrupt the actin cytoskeleton in leading edge cells, with2000). However, combining these two backgrounds to
subsequent effects on dorsal closure. Intense trio ex-generate trio, Abl homozygous mutant embryos results
pression in leading edge cells may indicate that Trioin dramatic disruption of the CNS scaffolding (Figures
plays a role in this process. Eaton et al. (1995) have4G and 4L). Taken alone, this synthetic enhancement
shown that expressing dominant-negative Cdc42 pro-may represent common or independent signaling path-
teins in wing discs can produce wing blisters similar toways involving Abl and Trio (for example, Elkins et al.,
those we have observed in the trio hypomorphic back-1990). However, combined with the dosage-sensitive
ground. Mutations in inflated, a Drosophila integrin, pro-interactions between Abl and trio observed (see above),
duce similar wing blisters, as well (Brower and Jaffe,it is likely that these molecules are involved in overlap-
1989). As the mammalian c-Abl kinase is activated inping or interdependent networks. Similar synergistic ef-
response to integrin-mediated cell adhesion (Lewis etfects between Abl and fax, and Abl and dab, have been
reported (Gertler et al., 1989; Hill et al., 1995). al., 1996), and Abl is expressed in wing imaginal disc
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1993), and stocks with second chromosome insertions in the trioM89,epithelial cells (Bennett and Hoffmann, 1992), the blis-
Abl1 background were generated. These were crossed to stockstered wing phenotype seen in trio hypomorphic animals
with the scabrous GAL4 driver (Mlodzik at al., 1990) on the secondpotentially presents a modifiable phenotype with which
chromosome, and Df(3L)FpaI, Abl4 on the third.
to explore additional aspects of Trio signaling networks.
In summary, we have identified a novel Drosophila In Situ Analysis and Antibody Staining of Embryos
gene, trio, that encodes a protein highly similar to the In situ staining was carried out on Canton-S embryos using DIG-
N-terminal 80% of the human protein Trio. This gene 11-UTP-labeled, single stranded RNA probes, as described (O'Neill
and Bier, 1994). Antibody staining was carried out on 0±24 hr em-is expressed in the developing CNS and has dosage-
bryos, which were collected, fixed, and stained with modificationssensitive interactions with Abl, fax, dab, and ena. trio's
of published procedures (Patel et al., 1987). mAb BP102 was ob-dosage-sensitive interactions with Abl have dramatic
tained from the Developmental Studies Hybridoma Bank (University
phenotypic consequences on the embryonic CNS, rais- of Iowa, Iowa City, IA). mAb 1D4 was a gift of Dr. C. Goodman
ing the strong possibility of a role for Trio in axon path- (University of California, Berkeley). Horseradish peroxidase±conju-
finding. Ongoing genetic and biochemical studies of trio gated secondary antibodies were obtained from Jackson (West Grove,
PA). Mouse monoclonal anti-b-galactosidase antibody (Promega,will clarify its place in neuronal guidance networks.
Madison, WI) was used to detect lacZ expression from enhancer
trap±containing balancer chromosomes to distinguish embryos' ge-Experimental Procedures
notypes.
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